Latest Update on Covid-19 cases worldwide is more than 520 million which obviously has created monumental imbalance to our accepted way of life, removed the illusion of host dominance and thrown a glaring spotlight on some of the tiniest members of society —viruses. Also its correlation with Influenza during seasons has effected greatly. The flu and COVID-19 are both primarily spread via small, virus-laced particles called respiratory droplets that are released when an infected person coughs, sneezes, talks or simply exhales. Someone who is nearby may inhale these droplets or become infected through physical contact, like handshaking or hugging, by touching their own nose or mouth.

Importantly, individuals do not need to exhibit symptoms to be contagious. Both COVID-19 and the flu can be transmitted by presymptomatic, asymptomatic and mildly symptomatic individuals. Accurate diagnosis requires laboratory testing to identify genetic or molecular components of the infecting virus.

According to mentioned data from World Health Organization (WHO), U.S. National Institutes for Health (NIH) as well as Centers for Disease Control (CDC) have released guidelines stressing that diagnostic testing is the only reliable method to distinguish viral infections caused by SARS-CoV-2, influenza, or a co-infection of both viruses. COVID-19 and flu share common symptoms like fever, cough and shortness of breath, among others, making it difficult to differentiate based on symptoms alone. Covid-19 and Flu symptoms you shouldn’t ignore:

As social distancing measures decrease, influenza transmission may increase. At the same time, experts believe that COVID-19 will continue to circulate endemically. As a result, both COVID-19 and flu are likely to co-circulate. Rapid testing remains an important to manage respiratory illness unpredictability. THE SEVERITY OF THE COVID-19 AND FLU IS UNPREDICTABLE

MORE THAN EVER, DIAGNOSTICS ARE NEEDED TO APPROPRIATELY IDENTIFY, TREAT, AND CONTROL SPREAD

With similar symptoms for SARS-CoV-2 and Influenza A and B, healthcare professionals need to quickly determine which infection is potentially present. The SARS-CoV-2 & Flu A/B Rapid Antigen Test helps healthcare professionals at the point of care to quickly diagnose and differentiate infections with any of the three respiratory viruses and aid in pursuing appropriate courses of action, including patient and pandemic management decisions. Also, it enables scaling up test capacities during flu season to meet the need for extensive testing during peak periods.

Biotime HAS RAPID POINT-OF-CARE SOLUTIONS TO SUPPORT YOUR COVID-19 AND INFLUENZA TESTING NEEDS

Handytest COVID-19 Ag & Flu A/B Combo, CE Approved Self testing kit is a colloidal gold immunochromatography intended for the in vitro rapid, simultaneous qualitative detection and differentiation of N protein from SARS-CoV-2, influenza A and influenza B directly from nasal swab specimens obtained from individuals, who are suspected of COVID-19 with symptomatic individuals within 7 days post symptoms onset and asymptomatic individuals, influenza A or influenza B infection.

What is a Handytest?

Self-tests for COVID-19 and Flu A/B give rapid results and can be taken anywhere, regardless of your vaccination status or whether or not you have symptoms.

Is Handytest COVID-19 Ag & Flu A/B Combo self-testing difficult to use?

You can take a self-test at home or virtually anywhere, they are easy to use, and produce quick results.

What Your Test Results Mean

Endnote

https://www.xiamenbiotime.com/covid-19-ag-flu-a-b-combo-self-test_p79.html

WHO. Coronavirus disease (COVID-19) advice for the public. Updated 7/1/2021.

NIH. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Accessed 7/26/2021.

CDC. Testing Guidance for Clinicians When SARS-CoV-2 and Influenza Viruses are Co-circulating. Updated 10/16/2020.

Hellewell et al. (2020) discuss factors that influence the success of isolation, testing, and contact tracing on COVID-19 outbreaks. Hellewell et al. ‘Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts’, The Lancet Global Health, volume 8, issue 4. Available here.